DK271083D0 - Praeparat til visualisering af blodlegemer - Google Patents

Praeparat til visualisering af blodlegemer

Info

Publication number
DK271083D0
DK271083D0 DK2710/83A DK271083A DK271083D0 DK 271083 D0 DK271083 D0 DK 271083D0 DK 2710/83 A DK2710/83 A DK 2710/83A DK 271083 A DK271083 A DK 271083A DK 271083 D0 DK271083 D0 DK 271083D0
Authority
DK
Denmark
Prior art keywords
visualization
preparation
blood bodies
bodies
blood
Prior art date
Application number
DK2710/83A
Other languages
English (en)
Other versions
DK271083A (da
Inventor
Madhukar Laxman Thakur
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of DK271083D0 publication Critical patent/DK271083D0/da
Publication of DK271083A publication Critical patent/DK271083A/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK271083A 1982-06-14 1983-06-13 Praeparat til visualisering af blodlegemer DK271083A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/387,731 US4443426A (en) 1982-06-14 1982-06-14 Blood agent

Publications (2)

Publication Number Publication Date
DK271083D0 true DK271083D0 (da) 1983-06-13
DK271083A DK271083A (da) 1983-12-15

Family

ID=23531147

Family Applications (1)

Application Number Title Priority Date Filing Date
DK271083A DK271083A (da) 1982-06-14 1983-06-13 Praeparat til visualisering af blodlegemer

Country Status (5)

Country Link
US (1) US4443426A (da)
EP (1) EP0096871A3 (da)
JP (1) JPS595164A (da)
CA (1) CA1215372A (da)
DK (1) DK271083A (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU580958B2 (en) * 1983-07-07 1989-02-09 Mallinckrodt, Inc. Sterile radioactive indium-containing aqueous solution
JPS61501321A (ja) * 1984-01-23 1986-07-03 インスティテュト・フォ−・エネジテクニク たんぱく様物質標識用テクネチウム９９ｍ組成物およびその使用方法
US4755375A (en) * 1984-01-27 1988-07-05 Associated Universities, Inc. Method and kit for the selective labeling of red blood cells in whole blood with TC-99M
JPS61171902A (ja) * 1985-01-22 1986-08-02 Kobe Steel Ltd 複数アクチユエ−タの油圧制御回路
DE3670571D1 (de) * 1985-07-05 1990-05-31 Causse Jean Etienne Verfahren zur reduktion von pertechnetat.
US5145661A (en) * 1988-08-31 1992-09-08 Wayne State University Method and contrast agent for use in magnetic resonance imaging of abscess
DE68924783T2 (de) * 1988-09-30 1996-03-28 Neorx Corp Wässrige additivsysteme, verfahren und polymerteilchen.
US5066789A (en) * 1988-09-30 1991-11-19 Neorx Corporation Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages
US4986979A (en) * 1989-03-14 1991-01-22 Neorx Corporation Imaging tissue sites of inflammation
US5279968A (en) * 1989-07-20 1994-01-18 Syncor International Corporation Method of labelling leucocytes with Tc-99m, d,1-HMPAO
US5336482A (en) * 1991-12-05 1994-08-09 The Du Pont Merck Pharmaceutical Company Technetium-99m complexes with N-substituted 3-hydroxy-4-pyridinones
US5900377A (en) * 1997-03-03 1999-05-04 Syncor International Corporation Method for isolating and radiolabeling leukocytes for use in vivo
US7419654B2 (en) * 2004-10-08 2008-09-02 Mrinal K. Dewanjee Charge neutral complexes of paramagnetic metals as intracellular magnetic resonance imaging contrast agents
WO2023238133A2 (en) * 2022-06-09 2023-12-14 Check-Cap Ltd. Nuclear radiation based capsule for gi bleeding detection and localization

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2809971A (en) * 1955-11-22 1957-10-15 Olin Mathieson Heavy-metal derivatives of 1-hydroxy-2-pyridinethiones and method of preparing same
US3988429A (en) * 1975-04-16 1976-10-26 The United States Of America As Represented By The United States Energy Research And Development Administration Kit for the rapid preparation of 99m Tc red blood cells
FR2390408A1 (fr) * 1977-05-11 1978-12-08 Philips France Procede de marquage par un isotope radioactif d'un sel hydrosoluble d'oxine, ou de ses derives halogenes ou sulfones, produits ainsi marques, procede de marquage des elements figures du sang, et medicaments ainsi obtenus
CA1105815A (en) * 1977-06-17 1981-07-28 Paul-Emile Bonneau Red blood cell labelling kit
JPS5569517A (en) * 1978-11-20 1980-05-26 Nippon Mejifuijitsukusu Kk Labelling preparation for labelling of erythrocytes with radio-active technetium
US4335095A (en) * 1979-03-21 1982-06-15 The Radiochemical Centre Limited Indium-111 oxine complex composition
US4348375A (en) * 1979-12-31 1982-09-07 Byk-Mallinckrodt Cil B.V. Radioassay process and compositions useful therein
US4342740A (en) * 1980-08-18 1982-08-03 E. R. Squibb & Sons, Inc. Method and kit for labeling red blood cells with technetium-99m
US4372294A (en) * 1980-09-25 1983-02-08 The Massachusetts General Hospital Method and apparatus for radiolabeling red blood cells
CA1222691A (en) * 1981-12-29 1987-06-09 Wilhelmus T. Goedemans Method of preparing radionuclide-labelled proteins, in particular antibodies or antibody fragments

Also Published As

Publication number Publication date
EP0096871A2 (en) 1983-12-28
CA1215372A (en) 1986-12-16
US4443426A (en) 1984-04-17
EP0096871A3 (en) 1984-03-28
JPS595164A (ja) 1984-01-12
DK271083A (da) 1983-12-15

Similar Documents

Publication Publication Date Title
DK1183A (da) Fremgangsmaade til fremstilling af tiazolidinderivater
DK301383A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK241883A (da) Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK271083D0 (da) Praeparat til visualisering af blodlegemer
DK153282A (da) Fremgangsmaade til fremstilling af bismethinisoindoliner
DK372283D0 (da) Fremgangsmade til fremstilling af desoxyuridinderivater
DK239382A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK309783D0 (da) Fremgangsmade til fremstilling af organoglykosider
DK305982A (da) Fremgangsmaade til fremstilling af amidobenzamider
DK119083D0 (da) Fremgangsmade til fremstilling af alkanoylpyridinoner
DK261883D0 (da) Fremgangsmade til fremstilling af prostaglandin-d-derivater
DK162230C (da) Fremgangsmaade til fremstilling af 2-thiacephemderivater
DK317283A (da) Fremgangsmaade til fremstilling af thiadiazolderivater
DK424083A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK185683D0 (da) Fremgangsmade til fremstilling af pleuromutilinderivater
DK165583D0 (da) Fremgangsmade til fremstilling af furanderivater
DK296383D0 (da) Fremgangsmade til fremstilling af fenaetylaminer
DK152051C (da) Fremgangsmaade til fremstilling af krystallinsk natriumcefoperazon
DK219483A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK62283A (da) Fremgangsmaade til fremstilling af peptidergotalkaloider
DK519183A (da) Fremgangsmaade til fremstilling af oxazolinoazetidinon-forbindelser
DK496183D0 (da) Fremgangsmade til fremstilling af nitroalkaner
DK10883A (da) Fremgangsmaade til fremstilling af substituerede chloracetanilider
DK145182A (da) Fremgangsmaade til fremstilling af amino-pyridiner
DK164283D0 (da) Fremgangsmade til fremstilling af benzimidazolderivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment